Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Tamoxifen, raloxifene worthwhile for high breast-cancer risk

    • 18 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Kondo M, Hoshi S-L, Toi M.Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan. British Journal of Cancer 100: 281-290, No. 2, 27 Jan 2009

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Tamoxifen, raloxifene worthwhile for high breast-cancer risk. Pharmacoecon. Outcomes News 573, 6 (2009). https://doi.org/10.2165/00151234-200905730-00018

    Download citation

    Keywords

    • Breast Cancer
    • Carcinoma
    • Health Outcome
    • Cancer Risk
    • Tamoxifen